logo
  1. Home
  2. Stocks
  3. Aarti Pharmalabs

Aarti Pharmalabs Share Price

Small Cap | Pharmaceuticals and health care | NSE: AARTIPHARM | BSE: 543748

₹739.80 image9.55 (1.31 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 737.55

High (₹) 749.05

Low (₹) 728.55

Prev. Close (₹) 730.25

Volume 6,978

VWAP (₹) 729.26

ROCE (%) 16.83

Industry P/E 43.95

TTM P/E 26.89

P/B Ratio 3.81

Market Cap (₹) Cr.6,696.81

Dividend Yield (%)0.41

EPS (₹) 23.93

ROE12.34%

Sales Growth (%) -4.76

Profit Growth (%)12.10

Day Range

749.05749.05

L
H

52 Week Range

380.65837.00

L
H

Historical Returns

Returns (6M)

9.43 %

Returns (1Y)

66.81 %

Returns (3Y)

96.16 %

Returns (5Y)

96.16 %

Returns (6M)

9.43 %

Returns (1Y)

66.81 %

Returns (3Y)

96.16 %

Returns (5Y)

96.16 %

SWOT Analysis

  • Company with (12.08%) TTM EPS Growth
  • Company with Low Debt
  • Company with 12.08% positive TTM EPS growth
  • Growth in Net Profit Margin (QoQ)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Positive ROC (9) indicates upward momentum.
  • Price above the pivot point indicates bullish sentiment.
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 70.41

MFI 65.79

ATR 43.59

Commodity Channel Index 15.06

ROC125 4.77

ROC21 24.92

Williams %R -75.15

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current750.76767.48784.56733.68716.96699.88683.16
Week Ago793.36822.73842.31773.78744.41724.83695.46
Month Ago602.50618.45633.70587.25571.30556.05540.10

EMA & SMA
info_icon

739.80

Current Price

EMA & SMApin

Bullish Moving Averages

10

Bearish Moving Averages

10

5 Day 757.25

9 Day 775.62

10 Day 758.40

12 Day 752.90

14 Day 754.78

20 Day 710.24

26 Day 688.21

50 Day 666.05

100 Day 647.80

200 Day 634.89

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
BHAVNA SHANTILAL SHAHblockSell19 Dec, 2024₹565.105,13,000BSE
JAYA CHANDRAKANT GOGRIblockBuy19 Dec, 2024₹565.105,13,000BSE
BHAVNA SHANTILAL SHAHbulkSell19 Dec, 2024₹565.105,13,941BSE
JAYA CHANDRAKANT GOGRIbulkBuy19 Dec, 2024₹565.105,13,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
20 Feb, 2025TULIP FAMILY TRUST Gloire Trusteeship Services Private LimitedDisposal₹821.8655,000BSE
20 Feb, 2025ORCHID FAMILY TRUST Relacion Trusteeship Services Private LimitedDisposal₹811.3850,000BSE
14 Feb, 2025Anushakti Enterprise Private LimitedAcquisition₹734.1120,250BSE
14 Feb, 2025Narendra J SalviDisposal₹721.748,000BSE
13 Feb, 2023Manjula Mahendra SangoiAcquisition₹330.777,500BSE
13 Feb, 2023Labdhi Business Trust Saswat Trusteeship Private LimitedAcquisition₹331.651,50,000BSE
13 Feb, 2023Labdhi Business Trust Saswat Trusteeship Private LimitedAcquisition₹316.2669BSE
13 Feb, 2023Labdhi Business Trust Saswat Trusteeship Private LimitedAcquisition₹315.912,07,000BSE
13 Feb, 2023Labdhi Business Trust Saswat Trusteeship Private LimitedAcquisition₹317.9015,000BSE
13 Feb, 2023MANOMAYA BUSINESS TRUST Alabhya Trusteeship Private LimitedAcquisition₹329.292,14,287BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
05 Feb, 2025Rs.2.5000 per share(50%)Interim Dividend14 Feb, 202514 Feb, 2025
13 May, 2024Rs.1.0000 per share(20%)Final Dividend31 Jul, 202431 Jul, 2024
07 Feb, 2024Rs.2.0000 per share(40%)Interim Dividend16 Feb, 202419 Feb, 2024

Announcements

DateSourceDetail
10 Mar, 2025NSE IndiaAARTI PHARMALABS LIMITED has informed the Exchange regarding Allotment of Securities
10 Mar, 2025BSE IndiaAllotment of Shares under PSOP 2023
10 Mar, 2025NSE IndiaAarti Pharmalabs Limited has informed the Exchange regarding Allotment of 8616 Shares.
12 Feb, 2025BSE IndiaTranscript of Q3/9M Earnings Conference call
12 Feb, 2025NSE IndiaAarti Pharmalabs Limited has informed the Exchange about Transcript
07 Feb, 2025BSE IndiaRecording of the Earnings Conference call for Q3 FY 25
07 Feb, 2025NSE IndiaAarti Pharmalabs Limited has informed the Exchange about Link of Recording
07 Feb, 2025NSE IndiaAarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication
06 Feb, 2025BSE IndiaInvestor Presentation for the Quarter ended December 31, 2024
06 Feb, 2025NSE IndiaAarti Pharmalabs Limited has informed the Exchange about Presentation

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results, Dividend & OthersTo consider other business matters.29 Jan, 202505 Feb, 2025
Quarterly Results--22 Oct, 202428 Oct, 2024
Quarterly Results--30 Jul, 202405 Aug, 2024
Audited Results & Final Dividend--07 May, 202413 May, 2024
Quarterly Results & Interim Dividend--31 Jan, 202407 Feb, 2024
Quarterly Results--31 Oct, 202307 Nov, 2023
Quarterly Results--31 Jul, 202305 Aug, 2023
Audited Results--04 May, 202312 May, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Jun, 2024Mar, 2024Dec, 2023Sept, 2023

About Aarti Pharmalabs

Aarti Pharmalabs is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1502.13 Cr. and Equity Capital is Rs. 45.31 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Aarti Group

Founded

2019

Managing Director

Mr. Narendra J Salvi

NSE Symbol

AARTIPHARM

Aarti Pharmalabs Management

NameDesignation
Mr. Chandrakant Vallabhaji GogriChairman Emeritus
Mr. Rashesh C GogriChairman
Mrs. Hetal Gogri GalaVice Chairperson & M.D
Mr. Narendra J SalviManaging Director
Mr. Rajendra V GogriNon Executive Director
Mr. Parimal H DesaiNon Executive Director
Ms. Nehal GarewalNon Executive Director
Mr. Bhavesh R VoraIndependent Director
Mrs. Jeenal K SavlaIndependent Director
Mrs. Rupal A VoraIndependent Director
Mr. Vilas Gajanan GaikarIndependent Director
Dr. Vinay G NayakIndependent Director
Mr. Pradeep H ThakurIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)		₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)		₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)		₹1,093.000 - ₹1,420.200

FAQs on Aarti Pharmalabs

What is the share price of Aarti Pharmalabs?

The share price of Aarti Pharmalabs on 13 Mar, 2025 is ₹ 739.80.

What is 52W high and 52W low share price of Aarti Pharmalabs?

The highest and lowest 52W share prices of Aarti Pharmalabs are ₹ 837.000 and ₹ 380.650

What is the market cap of Aarti Pharmalabs?

The market capitalization of Aarti Pharmalabs as of 13 Mar, 2025 is ₹ 6,696.81 Crores

What is the P/E ratio of Aarti Pharmalabs?

The current P/E ratio of Aarti Pharmalabs as of 13 Mar, 2025 is 43.95

What is the PB ratio of Aarti Pharmalabs?

The PB ratio of Aarti Pharmalabs as of 13 Mar, 2025 is 3.81

Top Gainers

PASUSPG

Pasupati Spinning & Weaving Mills

₹41.02image

₹34.29 (0.20%)

OONE

ObjectOne Information Systems

₹8.84image

₹7.37 (0.20%)

JAINCO

Jainco Projects (India)

₹6.97image

₹5.81 (0.20%)

HITECHCORP

Hitech Corporation

₹194.70image

₹162.25 (0.20%)

Top Losers

MEHAI

Mehai Technology

₹13.75image

₹135.15 (-0.90%)

TRESCON

Trescon

₹9.60image

₹12.00 (-0.20%)

SAGL

Shalimar Agencies

₹9.80image

₹93.55 (-0.90%)

SHANGAR

Shangar Decor

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited